ALUDAIN Trademark

Trademark Overview

On Tuesday, June 2, 2009, a trademark application was filed for ALUDAIN with the United States Patent and Trademark Office. The USPTO has given the ALUDAIN trademark a serial number of 77750543. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 19, 2013. This trademark is owned by Glaxo Group Limited. The ALUDAIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
aludain

General Information

Serial Number77750543
Word MarkALUDAIN
Filing DateTuesday, June 2, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 19, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 20, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 8, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN
GB

Trademark Events

Event DateEvent Description
Monday, August 19, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 19, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 17, 2012EXTENSION 5 GRANTED
Friday, December 14, 2012EXTENSION 5 FILED
Friday, December 14, 2012TEAS EXTENSION RECEIVED
Thursday, July 19, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 18, 2012EXTENSION 4 GRANTED
Tuesday, July 17, 2012EXTENSION 4 FILED
Tuesday, July 17, 2012TEAS EXTENSION RECEIVED
Wednesday, January 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 10, 2012EXTENSION 3 GRANTED
Monday, January 9, 2012EXTENSION 3 FILED
Monday, January 9, 2012TEAS EXTENSION RECEIVED
Thursday, July 7, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 6, 2011EXTENSION 2 GRANTED
Tuesday, July 5, 2011EXTENSION 2 FILED
Tuesday, July 5, 2011TEAS EXTENSION RECEIVED
Thursday, December 23, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 22, 2010EXTENSION 1 GRANTED
Wednesday, December 1, 2010EXTENSION 1 FILED
Wednesday, December 22, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 1, 2010TEAS EXTENSION RECEIVED
Tuesday, July 20, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 4, 2010EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, April 9, 2010CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, April 7, 2010ASSIGNED TO PETITION STAFF
Monday, April 5, 2010TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, November 11, 2009EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 20, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 20, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2009PUBLISHED FOR OPPOSITION
Tuesday, September 15, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 15, 2009ASSIGNED TO LIE
Tuesday, September 8, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 1, 2009ASSIGNED TO EXAMINER
Monday, June 8, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 5, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

aludain pharmaceutical disorders treatment substances preparations diseases neurological hormonal gastrointestinal hepatological